Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $70,000.

  • Eton Pharmaceuticals' Amortizatization of Intangibles rose 551.72% to $189,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 1409.62%. This contributed to the annual value of $70,000 for FY2024, which is 40.17% down from last year.
  • Eton Pharmaceuticals' Amortizatization of Intangibles amounted to $70,000 in FY2024, which was down 40.17% from $117,000 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $148,000 in FY2021 and a low of $70,000 during FY2024.
  • Its 3-year average for Amortizatization of Intangibles is $104,667, with a median of $117,000 in 2023.
  • Per our database at Business Quant, Eton Pharmaceuticals' Amortizatization of Intangibles surged by 656.25% in 2020 and then crashed by 40.17% in 2024.
  • Eton Pharmaceuticals' Amortizatization of Intangibles (Yearly) stood at $121,000 in 2020, then rose by 22.31% to $148,000 in 2021, then decreased by 14.19% to $127,000 in 2022, then declined by 7.87% to $117,000 in 2023, then crashed by 40.17% to $70,000 in 2024.